Rising Prevalence Of Neurological Disorders To Drive Growth In Implantable Neurostimulation Device Market: A Key Factor Shaping the Future of the Implantable Neurostimulation Devices Market in 2025

How Are the key drivers contributing to the expansion of the implantable neurostimulation devices market?
The growth of the implantable neurostimulation device market is anticipated to be fueled by the increased incidences of neurological disorders. Neurological disorders, defined as conditions impacting the structure or function of the nervous system, can lead to a variety of symptoms, including paralysis, seizures, and cognitive impairments. The detection rates of neurological disorders have risen, owing to greater exposure to risk factors such as high blood pressure, developmental abnormalities, and trauma or injury. When other treatments prove ineffective or inadequate, implantable neurostimulation devices, designed to modulate nerve activity, are used for the management of neurological disorders. For example, data from the Alzheimer's Association, a US-based non-profit voluntary health organization, suggests that in 2024, approximately 6.9 million Americans aged 65 and older are projected to be living with Alzheimer's disease, with about 73% of these individuals being aged 75 or older. This figure is expected to surge to 12.7 million by 2050. As such, the surge in neurological disorders is predicted to be a driving force for the implantable neurostimulation device market.

Get Your Implantable Neurostimulation Devices Market Report Here:
https://www.thebusinessresearchcompany.com/report/implantable-neurostimulation-devices-global-market-report

What growth opportunities are expected to drive the implantable neurostimulation devices market's CAGR through 2034?
The market for implantable neurostimulation devices has seen substantial growth in recent years. The market is slated to expand from $8.68 billion in 2024 to $9.64 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.1%. The surge in growth during the historic period is due to factors such as heightened demand for non-drug treatments, increased preference for minimally invasive procedures, a growing elderly population, a widening spectrum of mental health disorders, and a rise in the prevalence of chronic diseases.

The market for implantable neurostimulation devices is projected to experience a significant expansion in the coming years, with a surge to $14.53 billion by 2029, registering a compound annual growth rate (CAGR) of 10.8%. This growth during the prediction period can be credited to a multitude of factors such as increasing instances of neurological disorders, higher occurrence of lifestyle-related diseases, improved awareness, a rise in spinal cord injuries, and escalating healthcare expenditures. Prime trends that are expected to shape the forecast period include sensing technology, ongoing improvements in neurostimulation technologies, technologically superior products, the incorporation of closed-loop systems and the integration of wireless technology.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19520&type=smp

What are the emerging trends shaping the future of the implantable neurostimulation devices market?
Leading businesses in the implantable neurostimulation devices market are concentrating their efforts on the creation of advanced technological products, such as spinal cord stimulation (SCS) systems, to alleviate severe pain conditions. Dependence on electrical impulses to control nerve activity in the spinal cord, a spinal cord stimulation (SCS) system, is an effective medical device that significantly improves patients' quality of life when other treatments fail to deliver results. As an example, Abbott, an American medical device firm, reported in December 2022 that the U.S. Food and Drug Administration (FDA) had approved their Eterna spinal cord stimulation (SCS) system. The Eterna SCS, the smallest implantable, rechargeable spinal cord stimulator in the market, is designed with an emphasis on comfort. Abbott's unique BurstDR stimulation technology, which imitates the brain's natural firing patterns for maximum pain relief and is favored by 87% of patients over conventional tingling stimulation, is included in this system. Eterna's low charging requirement, needing as little as five recharges a year due to Xtend energy technology, assures user convenience. Additionally, the system is MRI-friendly, with TotalScan technology and can adapt to any future enhancements without needing a replacement. Integration with a mobile app from Abbott also permits real-time monitoring of the device's battery life and charging status on iPhones.

Which growth-oriented segments of the implantable neurostimulation devices market are leading the industry's development?
The implantable neurostimulation devicesmarket covered in this report is segmented -

1) By Type: Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Other Types
2) By Application: Pain Management, Parkinson's Disease, Urinary And Fecal Incontinence, Epilepsy, Gastroparesis, Other Applications
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers

Subsegments:
1) By Spinal Cord Stimulation (SCS): Rechargeable SCS Devices, Non-Rechargeable SCS Devices
2) By Gastric Electric Stimulation (GES): Implantable Gastric Stimulators, Adjustable Gastric Stimulators
3) By Deep Brain Stimulation (DBS): DBS Devices for Movement Disorders, DBS Devices for Psychiatric Disorders
4) By Sacral Nerve Stimulation (SNS): SNS Devices for Urinary Incontinence, SNS Devices for Fecal Incontinence
5) By Vagus Nerve Stimulation (VNS): VNS Devices for Epilepsy, VNS Devices for Depression
6) By Other Types: Peripheral Nerve Stimulation (PNS), Cortical Stimulation Devices, Novel Neurostimulation Technologies

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19520

What regions are leading the charge in the implantable neurostimulation devices market?
North America was the largest region in the implantable neurostimulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the implantable neurostimulation devices market?
Major companies operating in the implantable neurostimulation devices market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Dignity Health, St. Jude Medical LLC, LivaNova PLC, Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., CURE Epilepsy, Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Pain Management NYC, Curonix LLC

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=19520&type=smp

What Is Covered In The Implantable Neurostimulation Devices Global Market Report?

•Market Size Forecast: Examine the implantable neurostimulation devices market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the implantable neurostimulation devices market for a structured understanding.
•Key Players Overview: Analyze major players in the implantable neurostimulation devices market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the implantable neurostimulation devices market.
•Segment Contributions: Evaluate how different segments drive overall growth in the implantable neurostimulation devices market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the implantable neurostimulation devices market.
•Industry Challenges: Identify potential risks and obstacles affecting the implantable neurostimulation devices market.
•Competitive Landscape: Review strategic developments in the implantable neurostimulation devices market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.